July 22, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Demodex blepharitis is a common inflammatory eyelid condition with meaningful consequences for patients’ daily functioning and quality of life. As awareness grows and diagnostic guidance evolves, clinicians are also navigating a rapidly expanding management landscape that now includes prescription antiparasitic therapy, established lid hygiene strategies and an emerging lotion-based
July 22, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Welcome back to Meibomian Gland Adventure Land! Last month, I offered a basic definition of “best practices” vs. standard of care…

Glaukos Announces Completion of Patient Enrollment in Phase 2 Study of GLK-321 for Demodex Blepharitis

More adults with moderate to severe atopic dermatitis receiving an investigational extended-release topical formulation vs. a…

PHOENIX — Most patients who used Xiidra eye drops had a “clinically meaningful” reduction in eye dryness by the 84th day of…

Patients with IgG4-related disease who received obexelimab demonstrated a 56% reduction in flare risk compared with those given…

The FDA granted regenerative medicine advanced therapy designation to EO2002 for the treatment of corneal edema secondary to…